# A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia

> **NCT03538041** · PHASE2 · COMPLETED · sponsor: **Incyte Corporation** · enrollment: 25 (actual)

## Conditions studied

- Autoimmune Hemolytic Anemia

## Interventions

- **DRUG:** Parsaclisib

## Key facts

- **NCT ID:** NCT03538041
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-21
- **Primary completion:** 2021-08-05
- **Final completion:** 2024-04-02
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03538041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03538041, "A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03538041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*